Can DCGI approved Molnupiravir bolster India's fight against COVID? Farhat Nasim3 Jan 2022 11:45 PM ISTNew Delhi: As countries prepare themselves to fight a possible 'next wave'. The new variant – Omicron has been making headline and a surge in Covid-19...
13 pharma majors to launch anti-COVID drug Molnupiravir Medical Dialogues Team1 Jan 2022 7:36 PM ISTNew Delhi: Thirteen Indian pharmaceutical companies, including Torrent, Cipla, Sun Pharma, Dr Reddy's, Natco, Mylan, Hetero, Optimus will be...
Cipla plans to launch Molnupiravir under brand name Cipmolnu Roshni Dhar31 Dec 2021 5:01 PM ISTCipla Limited announced that the company has been granted permission by the Drug Controller General of India (DCGI) for the launch of Molnupiravir in...
Covovax nod to strengthen immunization efforts in India: SII Roshni Dhar31 Dec 2021 10:30 AM ISTVaccine major serum institute of India (SII) on Tuesday said the approval for the covid-19 vaccine 'covovax' would strength immunization across India...
Health Bulletin 30/December/2021 Roshni Dhar30 Dec 2021 5:59 PM ISTHere are Top health stories of the dayNiti Aayog Releases Health Index NEET PG Impasse Continues, More Doctors Join Strike MBBS, BDS Admissions...
Biological E bags DCGI nod for Corbevax trials as booster dose Ruchika Sharma30 Dec 2021 12:39 PM ISTNew Delhi: The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3...
Cipla bags DCGI nod for COVID-19 oral antiviral, all set to launch Cipmolnu in India Ruchika Sharma28 Dec 2021 3:00 PM ISTMolnupiravir is an oral anti-viral that inhibits the replication of multiple RNA viruses including SARS-CoV-2.
Anti-COVID pill Molnupiravir, Covovax, Corbevax get CDSCO panel emergency use nod Ruchika Sharma28 Dec 2021 11:19 AM ISTAll the recommendations have been sent to the Drug Controller General of India (DCGI) for final approval.
DCGI approves Covaxin for children above 12 years Medical Dialogues Bureau27 Dec 2021 12:09 PM ISTNew Delhi : The Drugs Controller General of India (DCGI) has granted emergency use authorisation to indigenously-developed Bharat Biotech's Covaxin...
Biocon arm gets DCGI nod to initiate clinical study for Itolizumab Ruchika Sharma24 Dec 2021 1:13 PM ISTItolizumab is a clinical-stage, first-in-class anti-CD6 monoclonal antibody that selectively targets the CD6-ALCAM pathway.
Serum Institute seeks DCGI nod for Covishield as booster dose Ruchika Sharma2 Dec 2021 12:42 PM ISTNew Delhi: Serum Institute of India has sought from India's drug regulator approval for Covishield as a booster dose citing adequate stock of the...
161 seizures of COVID drugs, medical supplies made in black-marketing cases Ruchika Sharma1 Dec 2021 11:00 AM ISTNew Delhi: A total of 161 seizures of drugs and medical supplies like Remdesivir, Favipiravir and medical oxygen have been made by authorities in...
